Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
The American Journal of Physiology
|
April 1, 1994
Cardiovascular effects of human recombinant interleukin-1 beta in conscious rats
A Bataillard, J Sassard
Clinical Pharmacokinetics
|
September 24, 1999
Pharmacological properties of indapamide. Rationale for use in hypertension
A Bataillard, P Schiavi, J Sassard
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
October 12, 2007
[Importance of chromosome 17 in genetically hypertensive rats of the Lyon strain (LH): study of a consomic strain]
S Gilibert, J Sassard, A Bataillard
Fundamental & Clinical Pharmacology
|
November 30, 2005
An overview of the pharmacology and clinical efficacy of indapamide sustained release
J Sassard, A Bataillard, H McIntyre
Journal of Visceral Surgery
|
November 25, 2010
Clinical practice guidelines
B Fervers, J Carretier, A Bataillard
Journal of Hypertension
|
December 1, 1995
Silica attenuates hypertension in Lyon hypertensive rats
A Bataillard, C Renaudin, J Sassard
Journal of Hypertension
|
December 1, 1995
Partial transfer of genetic hypertension by lymphoid cells in Lyon rats
C Renaudin, A Bataillard, J Sassard
Journal De Chirurgie
|
November 14, 2009
[The patient's role in evidence-based medicine]
J Carretier, A Bataillard, B Fervers
Journal of Hypertension
|
January 1, 1991
Fetal liver cell transplantation fails to transfer hypertension from genetically hypertensive rats to normotensive rats of the Lyon strain
A Bataillard, M Vincent, J Sassard, et al.
International Journal of Immunopharmacology
|
January 1, 1989
Antihypertensive effect of an immunosuppressive agent, cyclophosphamide, in genetically hypertensive rats of the Lyon strain
A Bataillard, M Vincent, J Sassard, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
The American Journal of Physiology
|
April 1, 1994
Cardiovascular effects of human recombinant interleukin-1 beta in conscious rats
A Bataillard, J Sassard
Clinical Pharmacokinetics
|
September 24, 1999
Pharmacological properties of indapamide. Rationale for use in hypertension
A Bataillard, P Schiavi, J Sassard
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
October 12, 2007
[Importance of chromosome 17 in genetically hypertensive rats of the Lyon strain (LH): study of a consomic strain]
S Gilibert, J Sassard, A Bataillard
Fundamental & Clinical Pharmacology
|
November 30, 2005
An overview of the pharmacology and clinical efficacy of indapamide sustained release
J Sassard, A Bataillard, H McIntyre
Journal of Visceral Surgery
|
November 25, 2010
Clinical practice guidelines
B Fervers, J Carretier, A Bataillard
Journal of Hypertension
|
December 1, 1995
Silica attenuates hypertension in Lyon hypertensive rats
A Bataillard, C Renaudin, J Sassard
Journal of Hypertension
|
December 1, 1995
Partial transfer of genetic hypertension by lymphoid cells in Lyon rats
C Renaudin, A Bataillard, J Sassard
Journal De Chirurgie
|
November 14, 2009
[The patient's role in evidence-based medicine]
J Carretier, A Bataillard, B Fervers
Journal of Hypertension
|
January 1, 1991
Fetal liver cell transplantation fails to transfer hypertension from genetically hypertensive rats to normotensive rats of the Lyon strain
A Bataillard, M Vincent, J Sassard, et al.
International Journal of Immunopharmacology
|
January 1, 1989
Antihypertensive effect of an immunosuppressive agent, cyclophosphamide, in genetically hypertensive rats of the Lyon strain
A Bataillard, M Vincent, J Sassard, et al.
Page
of 5